CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS

This adverse event was reported 120 times

These drugs are most commonly taken by patients reporting CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS:

# Drug Count
0 ADALIMUMAB 85
1 ADALIMUMAB-AATY 67
2 ADALIMUMAB-ADAZ 67
3 ADALIMUMAB-FKJP 67
4 METHOTREXATE SODIUM 38
5 INFLIXIMAB 31
6 METHOTREXATE 27
7 ETANERCEPT 20
8 USTEKINUMAB 19
9 CANAKINUMAB 8
See all common drugs associated with CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS

CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ADALIMUMAB-FKJP 67 0.0015
1 ADALIMUMAB-AATY 67 0.0014
2 ADALIMUMAB-ADAZ 67 0.0012
3 OMADACYCLINE 2 0.0012
4 ALGLUCOSIDASE ALFA 2 0.0008
5 CANAKINUMAB 8 0.0007
6 CEFOTAXIME INJECTION 2 0.0005
7 GOLIMUMAB 4 0.0003
8 CLOFAZIMINE 2 0.0003
9 USTEKINUMAB 19 0.0002
See all drugs enriched for association with CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS